Home/ Supplements/ Dhea/ Mass Pro

Mass Pro

product on market Capsule Centurion Labz Safety: 87/100
87/100

This product is generally safe

  • Dehydroepiandrosterone: 100mg is 2.0× the Tolerable Upper Intake Level (50mg)
  • Limited research evidence available for ingredients
C Label Compliance Grade
Alerts

Safety Alerts

Dehydroepiandrosterone: 100mg is 2.0× the Tolerable Upper Intake Level (50mg)

Label

Product Label

Label for Mass Pro
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

3beta-Hydroxy-5-androstan-17-one
300 mg
(-)-Epicatechin
150 mg
Exceeds UL by 2.0× (UL: 50 mg) 17 studies — no high-quality reviews

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide FD&C Blue #1 FD&C Red #40
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Formulation Notes

Mass gaining formula

Metadata

Product Details

DSLD Entry Date2020-04-23
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID218358
Data Updated2026-04-11
Research

Research Evidence

30
Research Sources
49
Avg Quality
21
Rct
5
Meta Analysis
2
Systematic Review
1
Other
1
Guideline
A Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
B Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis
Meta Analysis Annals of medicine 2025 PubMed DOI
B Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2021 PubMed DOI
B Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.
Guideline Ginekologia polska 2020 PubMed DOI
B Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis
Rct The Journal of clinical endocrinology and metabolism 2016 PubMed DOI
C Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients
Rct The Journal of clinical endocrinology and metabolism 2008 PubMed DOI
C Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Rct The lancet. Healthy longevity PubMed DOI
C Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA)
Rct Clinica chimica acta; international journal of clinical chemistry 2014 PubMed DOI
C Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement
Rct The Journal of clinical endocrinology and metabolism 2006 PubMed
View all evidence for Dhea →
Compare

Similar Products

View all Dhea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.